177 related articles for article (PubMed ID: 16040852)
1. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.
de Loor H; Bammens B; Evenepoel P; De Preter V; Verbeke K
Clin Chem; 2005 Aug; 51(8):1535-8. PubMed ID: 16040852
[No Abstract] [Full Text] [Related]
2. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
[TBL] [Abstract][Full Text] [Related]
3. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
[TBL] [Abstract][Full Text] [Related]
4. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.
Meijers BK; Weber V; Bammens B; Dehaen W; Verbeke K; Falkenhagen D; Evenepoel P
Artif Organs; 2008 Mar; 32(3):214-9. PubMed ID: 18201285
[TBL] [Abstract][Full Text] [Related]
5. Can oral therapy reduce uremic toxins?
Depner TA; Cowgill LD
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1513-5. PubMed ID: 25147156
[No Abstract] [Full Text] [Related]
6. Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.
Meert N; Schepers E; Glorieux G; Van Landschoot M; Goeman JL; Waterloos MA; Dhondt A; Van der Eycken J; Vanholder R
Nephrol Dial Transplant; 2012 Jun; 27(6):2388-96. PubMed ID: 22167586
[TBL] [Abstract][Full Text] [Related]
7. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
8. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.
Niwa T
Clin Chem; 1993 Jan; 39(1):108-11. PubMed ID: 8419031
[TBL] [Abstract][Full Text] [Related]
9. Comparative kinetics of the uremic toxin p-cresol versus creatinine in rats with and without renal failure.
Lesaffer G; De Smet R; D'Heuvaert T; Belpaire FM; Lameire N; Vanholder R
Kidney Int; 2003 Oct; 64(4):1365-73. PubMed ID: 12969155
[TBL] [Abstract][Full Text] [Related]
10. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
[TBL] [Abstract][Full Text] [Related]
11. Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications.
Pignanelli M; Bogiatzi C; Gloor G; Allen-Vercoe E; Reid G; Urquhart BL; Ruetz KN; Velenosi TJ; Spence JD
J Ren Nutr; 2019 Jan; 29(1):55-64. PubMed ID: 30100156
[TBL] [Abstract][Full Text] [Related]
12. New insights into uremic toxicity.
Raff AC; Meyer TW; Hostetter TH
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent increase in serum levels of indoxyl sulphate and p-cresol sulphate is not related to their precursors: Tryptophan and tyrosine.
Wyczalkowska-Tomasik A; Czarkowska-Paczek B; Giebultowicz J; Wroczynski P; Paczek L
Geriatr Gerontol Int; 2017 Jun; 17(6):1022-1026. PubMed ID: 27240996
[TBL] [Abstract][Full Text] [Related]
14. Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?
Vanholder R; Meert N; Van Biesen W; Meyer T; Hostetter T; Dhondt A; Eloot S
Nat Clin Pract Nephrol; 2009 Mar; 5(3):130-1. PubMed ID: 19107105
[No Abstract] [Full Text] [Related]
15. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
[TBL] [Abstract][Full Text] [Related]
16. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
[TBL] [Abstract][Full Text] [Related]
17. A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
Boelaert J; Lynen F; Glorieux G; Eloot S; Van Landschoot M; Waterloos MA; Sandra P; Vanholder R
Anal Bioanal Chem; 2013 Feb; 405(6):1937-47. PubMed ID: 23307120
[TBL] [Abstract][Full Text] [Related]
18. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
Bammens B; Evenepoel P; Keuleers H; Verbeke K; Vanrenterghem Y
Kidney Int; 2006 Mar; 69(6):1081-7. PubMed ID: 16421516
[TBL] [Abstract][Full Text] [Related]
19. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization.
Lesaffer G; De Smet R; Belpaire FM; Van Vlem B; Van Hulle M; Cornelis R; Lameire N; Vanholder R
Nephrol Dial Transplant; 2003 Jul; 18(7):1299-306. PubMed ID: 12808165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
